HBK Investments’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-471,500
Closed -$77M 122
2022
Q3
$77M Buy
471,500
+141,400
+43% +$23.9M 0.55% 18
2022
Q2
$58.6M Buy
+330,100
New +$58.8M 0.33% 25
2022
Q1
Sell
-6,100
Closed -$1.04M 765
2021
Q4
$1.04M Sell
6,100
-40,300
-87% -$6.6M ﹤0.01% 471
2021
Q3
$7.49M Sell
46,400
-1,700
-4% -$290K 0.03% 161
2021
Q2
$7.92M Sell
48,100
-23,400
-33% -$3.87M 0.03% 163
2021
Q1
$11.8M Buy
71,500
+56,100
+364% +$9.08M 0.05% 92
2020
Q4
$2.42M Sell
15,400
-6,300
-29% -$930K 0.02% 397
2020
Q3
$3.23M Buy
21,700
+1,600
+8% +$237K 0.02% 293
2020
Q2
$2.83M Buy
+20,100
New +$2.93M 0.04% 259
2020
Q1
Sell
-2,500
Closed -$365K 273
2019
Q4
$365K Sell
2,500
-48,500
-95% -$6.58M ﹤0.01% 598
2019
Q3
$6.6M Buy
+51,000
New +$6.72M 0.08% 196
2019
Q2
Sell
-37,600
Closed -$5.26M 841
2019
Q1
$5.26M Buy
+37,600
New +$5.04M 0.05% 297

Other funds holding JNJ

HBK Investments's JNJ Position: Q3 2023 in Review

HBK Investments sold out of Johnson & Johnson (JNJ) in Q3 2023, closing a stake of 8,455 shares — an estimated $1.4M sold.

HBK Investments first reported a position in JNJ in Q3 2013 and held it in 22 quarters. The position peaked at $60.2M in Q1 2017. 3,678 funds tracked by Wall St. Rank hold JNJ as of Q3 2023.

  • HBK Investments reported no remaining Johnson & Johnson position as of Q3 2023 after selling out during the quarter.
  • HBK Investments sold 8,455 Johnson & Johnson shares in Q3 2023, an estimated $1.4M.
  • HBK Investments first reported a position in Johnson & Johnson in Q3 2013 and held it in 22 quarters.
  • HBK Investments's Johnson & Johnson position peaked at $60.2M in Q1 2017.
  • 3,678 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2023.

Based on HBK Investments's 13F filing for Q3 2023, filed 14 Nov 2023.